Chronic subclinical spondylotic myelopathy exacerbated by COVID-19: A case report [0.03%]
慢性亚临床脊椎病性脊髓病因COVID-19加重的病例报告
Parménides Guadarrama-Ortiz,José Alberto Choreño-Parra,Francisco Javier Pacheco-Sánchez et al.
Parménides Guadarrama-Ortiz et al.
Introduction: Besides typical respiratory symptoms, the coronavirus disease 2019, also known as COVID-19, is characterized by a wide range of neurological symptoms that result from the injury of the brain and peripheral n...
Modification of neurosurgical practice during corona pandemic: Our experience at AIIMS patna and long term guidelines [0.03%]
新冠疫情期间神经外科实践的改变：我们在艾姆斯 Patna 的经验及长期指导意见
Saraj Kumar Singh,Vishal Abhijit,Vikas Chandra Jha
Saraj Kumar Singh
Background: First case of covid-19 was confirmed on 30th January 2020 in India. Our state, Bihar reported its first confirmed case of covid on 22nd march 2020 at AIIMS Patna. For safety, Electives surgeries and outpatient...
Nicolas K Khattar,Mayur Sharma,Abigail P McCallum et al.
Nicolas K Khattar et al.
COVID-19 patients are increasingly understood to develop multisystem manifestations, including neurologic involvement. We report the case of a 42-year old COVID-19 positive patient with a fatal intracerebral hemorrhage (ICH). The patient pr...
Necessity of brain imaging in COVID-19 infected patients presenting with acute neurological deficits [0.03%]
出现急性神经缺陷的COVID-19患者的脑部影像检查必要性
Laila Malani Mohammad,James A Botros,Muhammad Omar Chohan
Laila Malani Mohammad
Background: Patients undergoing cardiopulmonary stabilization in the intensive care unit for novel coronavirus (COVID-19) are often sedated, placing timely assessment of a neurological decline at risk. ...
Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report [0.03%]
以严重头痛为唯一表现症状的COVID-19肺炎：病例报告
Henrika Kimambo,Jerome H Chin,Mohammed Mnacho et al.
Henrika Kimambo et al.
The spectrum of symptoms of COVID-19 continues to expand as more clinical observations are reported. Neurological manifestations including headache are increasingly described. However, headache as the sole presenting symptom of COVID-19 pne...
COVID-19 and its impact on Neurosurgery: Our Early Experience in Lombok Island Indonesia [0.03%]
COVID-19对神经外科的影响：我们在印度尼西亚松巴岛的初步经验
Rohadi Muhammad Rosyidi,Bambang Priyanto,Dewa Putu Wisnu Wardhana et al.
Rohadi Muhammad Rosyidi et al.
Cerebellar infarction requiring surgical decompression in patient with COVID 19 pathological analysis and brief review [0.03%]
COVID-19患者的脑梗死需要手术减压的病理分析及简要回顾
Hiren N Patel,Asma Syed,Jeffrey S Lobel et al.
Hiren N Patel et al.
Background: This report and literature review describes a case of a COVID-19 patient who suffered a cerebellar stroke requiring neurosurgical decompression. This is the first reported case of a sub-occipital craniectomy w...
Clipping of a ruptured middle cerebral artery aneurysm in a patient with coronavirus disease 2019 (COVID-19): A case report [0.03%]
新型冠状病毒病(COVID-19)患者中报道一例破裂的脑中动脉瘤夹闭术
Kacper Kostyra,Błażej Nowak,Bogusław Kostkiewicz
Kacper Kostyra
Aim of the study: The aim of this study is to present our suggestions for organization, personal protective equipment (PPE) use, work flow of the operating theater, and the treatment of patients with COVID-19 and co-exist...
Evaluating the evidence for direct central nervous system invasion in patients infected with the nCOVID-19 virus [0.03%]
评估nCOVID-19病毒感染患者中枢神经系统直接入侵的证据
Patrick Lekgwara,Adrian Kelly
Patrick Lekgwara
The current nCOVID-19 pandemic is raising several questions in the approximately 25% of patients who present with neurological symptoms. While secondary brain injury from the systemic manifestations of the disease account for the majority o...
Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect [0.03%]
COVID-19合并卒中患者中肾素血管紧张素系统治疗的靶点：对其有害和有益作用的关注进展
Sabino Luzzi,Alice Giotta Lucifero,Stefano Marasco et al.
Sabino Luzzi et al.
Objective: The present short report summarizes some clinical characteristics of six patients affected by stroke while being on angiotensin-converting enzyme (ACE)2 inhibitors and angiotensin II receptor blockers (ARBs) be...